Develco Pharma Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
130
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
5
- Investments
-
1
Develco Pharma General Information
Description
Developer and manufacturer of orally administered modified-release pharmaceuticals intended for the treatment of severe pain and ADHD. The company offers innovative formulations for known active ingredients, including prolonged and chrono-release drugs, along with contract manufacturing and regulatory approval services, enabling international pharmaceutical groups to license and distribute complex dosage forms globally.
Contact Information
Website
www.develco.chCorporate Office
- Rührbergstrasse 21
- 4127 Birsfelden
- Switzerland
Corporate Office
- Rührbergstrasse 21
- 4127 Birsfelden
- Switzerland
Develco Pharma Timeline
Develco Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Develco Pharma Patents
Develco Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2018234568-A2 | Hydroxynorketamine for the use in the treatment of depression | Inactive | 23-Jun-2017 | ||
| WO-2018234568-A3 | Hydroxynorketamine for the use in the treatment of depression | Inactive | 23-Jun-2017 | ||
| AU-2018232854-A1 | Novel dosage form | Active | 09-Mar-2017 | ||
| AU-2018232854-B2 | Novel dosage form | Active | 09-Mar-2017 | ||
| CA-3053696-A1 | Novel dosage form | Active | 09-Mar-2017 | A61K9/167 |
Develco Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Develco Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Develco Pharma Investments (1)
Develco Pharma’s most recent deal was a Joint Venture with Ketabon. The deal was made on 01-Apr-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Ketabon | 01-Apr-2021 | Joint Venture | BPO/Outsource Services |
Develco Pharma FAQs
-
When was Develco Pharma founded?
Develco Pharma was founded in 2006.
-
Where is Develco Pharma headquartered?
Develco Pharma is headquartered in Birsfelden, Switzerland.
-
What is the size of Develco Pharma?
Develco Pharma has 130 total employees.
-
What industry is Develco Pharma in?
Develco Pharma’s primary industry is Pharmaceuticals.
-
Is Develco Pharma a private or public company?
Develco Pharma is a Private company.
-
What is Develco Pharma’s current revenue?
The current revenue for Develco Pharma is .
-
How much funding has Develco Pharma raised over time?
Develco Pharma has raised $11.1M.
-
Who are Develco Pharma’s investors?
Qualitas Funds and SHS Capital have invested in Develco Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
